CTOs on the Move

BioRx

www.biorx.com

 
Founded in 2004, BioRx is a national provider of specialty pharmacy, infusion management and industry consulting services. As a private, independently-owned company, BioRx is committed to a flexible service model that meets the needs of its customers, including consumers, healthcare providers, health plans and pharmaceutical manufacturers. The company’s streamlined management structure allows it to respond more quickly to changes in the marketplace and provide a higher level of service that is customized for each consumer. Moreover, BioRx helps to provide a more cost-effective level of healthcare – in particular by moving patients from costly facility-based infusion sites to their homes, thereby ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.biorx.com
  • 10828 Kenwood Rd
    Cincinnati, OH USA 45242
  • Phone: 866.442.4679

Executives

Name Title Contact Details

Similar Companies

GigHire

GigHire is a platform that connects healthcare facilities with per diem nurses for on-demand staffing needs.

Lakeshore Biomaterials

Lakeshore Biomaterials is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ohana Pacific

Ohana Pacific Health is a locally owned & operated health care management company in Hawaii. We treat everyone and each other like family.

Heritage Health Systems

Heritage Health Systems is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.